Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Gene Polymorphisms of Angiotensin II Type 1 Receptor and Angiotensin-Converting Enzyme in Two Ethnic Groups Living in Zhejiang Province, China

View through CrossRef
Polymorphisms of ACE insertion/deletion (I/D) and angiotensin II type 1 receptor (AT1R) 1166A-C have been associated with many diseases, and distributions of their genotypes vary in different races and populations. The aim of this study was to investigate distributions of angiotensin-converting enzyme (ACE) and AT1R genotypes in Han and She populations in ZheJiang province. We determined ACE and AT1R genotypes in 189 Han and 163 She individuals. DNA was extracted from peripheral blood samples. Analyses of ACE and AT 1R genotypes were performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). The frequencies of ACE genotypes and alleles among the Han sample (41.3%II, 41.3%ID, 17.5%DD; 61.9%I allele, 38.1%D allele) were similar to those among She individuals (39.9%II, 39.3%ID, 20.9%DD; 59.5%I allele, 40.5%D allele), with p=0.660; p=0.421. However, significant differences in the distributions of ACE polymorphism between men and women among She population were observed, with p=0.042, p=0.014. AT1R genotype and allele frequencies in the Han population were (88.4%AA, 11.1%AC, 0.5%CC) and (93.9%A allele, 6.1%C) allele respectively. In the She population they were (78.0%AA, 21.3%AC, 0.6%CC) and (89.0%A allele, 11.0%C allele). The significant differences were found between Han and She populations with p=0.031, p=0.018, and within subgroups of women, with p=0.010, p=0.021. There were no significant differences within subgroups of men (p=0.476, p=0.261). The genotype distributions or allele frequencies of ACE and AT1R were significantly different between the samples of the She and Han populations.
Title: Gene Polymorphisms of Angiotensin II Type 1 Receptor and Angiotensin-Converting Enzyme in Two Ethnic Groups Living in Zhejiang Province, China
Description:
Polymorphisms of ACE insertion/deletion (I/D) and angiotensin II type 1 receptor (AT1R) 1166A-C have been associated with many diseases, and distributions of their genotypes vary in different races and populations.
The aim of this study was to investigate distributions of angiotensin-converting enzyme (ACE) and AT1R genotypes in Han and She populations in ZheJiang province.
We determined ACE and AT1R genotypes in 189 Han and 163 She individuals.
DNA was extracted from peripheral blood samples.
Analyses of ACE and AT 1R genotypes were performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
The frequencies of ACE genotypes and alleles among the Han sample (41.
3%II, 41.
3%ID, 17.
5%DD; 61.
9%I allele, 38.
1%D allele) were similar to those among She individuals (39.
9%II, 39.
3%ID, 20.
9%DD; 59.
5%I allele, 40.
5%D allele), with p=0.
660; p=0.
421.
However, significant differences in the distributions of ACE polymorphism between men and women among She population were observed, with p=0.
042, p=0.
014.
AT1R genotype and allele frequencies in the Han population were (88.
4%AA, 11.
1%AC, 0.
5%CC) and (93.
9%A allele, 6.
1%C) allele respectively.
In the She population they were (78.
0%AA, 21.
3%AC, 0.
6%CC) and (89.
0%A allele, 11.
0%C allele).
The significant differences were found between Han and She populations with p=0.
031, p=0.
018, and within subgroups of women, with p=0.
010, p=0.
021.
There were no significant differences within subgroups of men (p=0.
476, p=0.
261).
The genotype distributions or allele frequencies of ACE and AT1R were significantly different between the samples of the She and Han populations.

Related Results

The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Angiotensin II has been shown to be a potent agent in the acceleration of wound repair. Angiotensin (1‐7), a fragment of angiotensin II that is not hypertensive, was found to be co...
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene (rs...
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Introduction: The renin-angiotensin-aldosterone system (RAAS) is involved in the regulation of the blood pressure, water- and electrolyte balance. Pathophysiologically,...
Studi Literatur Potensi Beberapa Ekstrak Tumbuhan Mengandung Katekin sebagai Antihipertensi
Studi Literatur Potensi Beberapa Ekstrak Tumbuhan Mengandung Katekin sebagai Antihipertensi
Abstract. High blood pressure or hypertension is one of the risks of cardiovascular disease with a high prevalence of death. Hypertension is a condition in which blood pressure exc...

Back to Top